ArticleThe Pan African medical journal2025
Retinitis pigmentosa with pre-mRNA processing factor 31 mutation: a case report of a Moroccan patient.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To report the clinical findings of a Moroccan patient presenting with retinitis pigmentosa (RP), together with pre-mRNA processing factor 31 (PRPF31) mutations. The patient experienced night blindness a few months before being diagnosed with RP in July 2023, and several ophthalmic examinations were carried out, including best-corrected visual acuity (BCVA) measurement, slit-lamp biomicroscopy, dilated ophthalmoscopy, fundus photography, optical coherence tomography (OCT), and electroretinogram (ERG). A genetic analysis was carried out to identify the causative genes in order to better understand the disease and facilitate the path to therapy. The variant found was in the PRPF31 gene at position c.1165C>T p(Gln389**), generating a stop codon and a loss of 110 amino acids. This mutation has previously been described as pathogenic and induces autosomal dominant RP. This is the first description of a Moroccan case presenting RP with a PRPF31 mutation. More cases are needed to better define the clinical progression and the range of mutations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.